Literature DB >> 21745302

NOD2 gene variants are a risk factor for culture-positive spontaneous bacterial peritonitis and monomicrobial bacterascites in cirrhosis.

Tony Bruns1, Jack Peter, Philipp A Reuken, Dominik H Grabe, Sonja R Schuldes, Julia Brenmoehl, Jürgen Schölmerich, Reiner Wiest, Andreas Stallmach.   

Abstract

BACKGROUND: Spontaneous bacterial peritonitis (SBP) is considered as result of bacterial translocation from the gastrointestinal lumen to the mesenteric lymph nodes and subsequent circulation. Variants of the NOD2 gene contribute to bacterial translocation and were associated with SBP in a recent study.
METHODS: We determined common NOD2 variants by TaqMan polymerase chain reaction and analysed the ascitic fluid neutrophil count and bacterial culture results in 175 prospectively characterized hospitalized patients with decompensated cirrhosis who underwent diagnostic paracentesis in two German centres.
RESULTS: Ten patients presented with culture-positive SBP, 19 with culture-negative SBP and six had bacterascites. Minor allele frequencies for R702W, G908R and 1007fs in subjects with sterile non-neutrocytic ascites were 3.2, 2.5 and 2.5% respectively. Patients with SBP [odds ratio (OR) 2.7; P=0.036], culture-positive SBP (OR 6.0; P=0.012) and bacterascites (OR 6.0; P=0.050) were more often carriers of NOD2 variants than patients with sterile non-neutrocytic ascites. The mutations 1007fs and G908R were associated with culture-positive SBP (P ≤ 0.005) and R702W with bacterascites (P=0.014). There was no significant association of NOD2 variants with culture-negative SBP (OR 1.6; P=0.493). In logistic regression, previous SBP, a higher model for end-stage liver disease (MELD) score and the presence of a NOD2 variant were independent predictors of ascitic fluid infection. The median survival was insignificantly shorter in patients with NOD2 variants (268 vs. 339 days; P=0.386). In patients without hepatocellular carcinoma at study entry (N=148), NOD2 was a predictor of survival after adjustment for the MELD score and age (hazard ratio 1.89; P=0.045).
CONCLUSION: NOD2 variants increase the risk for culture-positive SBP and bacterascites in cirrhosis and may affect survival.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21745302     DOI: 10.1111/j.1478-3231.2011.02561.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  19 in total

1.  Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.

Authors:  Georgios I Tsiaoussis; Stelios F Assimakopoulos; Athanassios C Tsamandas; Christos K Triantos; Konstantinos C Thomopoulos
Journal:  World J Hepatol       Date:  2015-08-18

Review 2.  Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver.

Authors:  Philipp Lutz; Hans Dieter Nischalke; Christian P Strassburg; Ulrich Spengler
Journal:  World J Hepatol       Date:  2015-03-27

3.  NOD2 Risk Variants and Pathological Bacterial Translocation in Decompensated Cirrhosis.

Authors:  Tony Bruns; Philipp A Reuken; Sven Stengel; Ludmila Gerber; Beate Appenrodt; Johannes H Schade; Frank Lammert; Stefan Zeuzem; Andreas Stallmach
Journal:  Dig Dis Sci       Date:  2016-04-06       Impact factor: 3.199

4.  Role of NOD2 in regulating the immune response to Aspergillus fumigatus.

Authors:  Zhuo-zhe Li; Li-Li Tao; Jing Zhang; Hui-jun Zhang; Jie-Ming Qu
Journal:  Inflamm Res       Date:  2012-03-07       Impact factor: 4.575

5.  Nucleotide-Binding Oligomerization Domain-Containing Protein 2 Variants in Patients with Spontaneous Bacterial Peritonitis.

Authors:  Murat M M Harputluoglu; Ramazan Dertli; Baris Otlu; Ulvi Demirel; Ozkan Yener; Yilmaz Bilgic; Mehmet Ali Erdogan; Yahya Atayan; Yasir Furkan Cagin
Journal:  Dig Dis Sci       Date:  2016-01-02       Impact factor: 3.199

Review 6.  Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis.

Authors:  Jane Macnaughtan; Rajiv Jalan
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864

Review 7.  Risk factors and outcome of bacterial infections in cirrhosis.

Authors:  Tony Bruns; Henning W Zimmermann; Andreas Stallmach
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

8.  Outcomes in Patients With Cirrhosis on Primary Compared to Secondary Prophylaxis for Spontaneous Bacterial Peritonitis.

Authors:  Jasmohan S Bajaj; Puneeta Tandon; Jacqueline G OʼLeary; Florence Wong; Scott W Biggins; Guadalupe Garcia-Tsao; Patrick S Kamath; Benedict Maliakkal; Michael B Fallon; Jennifer C Lai; Paul J Thuluvath; Hugo E Vargas; Ram M Subramanian; Leroy R Thacker; K Rajender Reddy
Journal:  Am J Gastroenterol       Date:  2019-04       Impact factor: 10.864

Review 9.  Intestinal Fibrosis and Liver Fibrosis: Consequences of Chronic Inflammation or Independent Pathophysiology?

Authors:  Florian Rieder; Dominik Bettenworth; Jin Imai; Yutaka Inagaki
Journal:  Inflamm Intest Dis       Date:  2016-03-19

10.  The gut microbiota and liver disease.

Authors:  Cristina Llorente; Bernd Schnabl
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2015-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.